Euromed Launching a New Extract at SSW17

Date: September 27 – 28, 2017
Location: Las Vegas, Nevada, USA

Our teams from Europe and US were busy at Stand NN123 providing information on the broad list of Euromed extracts, including our newest ABAlife™, an innovative fig fruit extract standardized in abscisic acid (ABA), indicated for blood glucose management, officially launched at SSW.

The development of ABAlife™ is the result of a partnership with BioTherapeutics (BTI) that was announced at SSW. As a part of this deal, BTI has granted an exclusive license to Euromed for patented technology for abscisic acid (ABA).

Dr. Josep Bassaganya-Riera, President and CEO of BTI, gave a presentation at our stand describing the key features of this innovative extract.